Drug-induced erythema multiforme is reported with many antimicrobial a
nd antipyretic medications. We present one patient who experienced ery
thema multiforme and urticaria after administration of pyrazinamide fo
r treatment of cutaneous tuberculosis. The side-effects of pyrazinamid
e include hepatic or dermatologic disorders, but erythema multiforme h
as not yet, to our knowledge, been described. Clinical features and di
scontinuation and reintroduction of the drug led us to consider pyrazi
namide the cause of the erythema multiforme, but allergologic studies
remained negative, except for the presence of circulating immune compl
exes. The mechanism of this eruption remains obscure, and definite wit
hdrawal of pyrazinamide seems to be the best therapeutic choice.